The Board of Directors of the Company in its meeting held on 12th September, 2026 have considered and approved the following matters; 1) To raise Fund for an amount not exceeding Rs. 65,00,00,000/- (Rupees Sixty Five crores only), through a Right Issue to the eligible equity shareholders of the Company as on Record date (to be notified subsequently), in accordance with applicable laws, including the Securities and Exchange Board of India (Issue ....

Aspira Pathlab & Diagnostics Limited Registered. Office: Flat No. 2, R D Shah Building, Shraddhanand Road, Opp. Railway Station, Ghatkopar (W), Mumbai-400086 Corporate Office: 6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (W), Mumbai-400086 CIN: L85100MH1973PLC289209 Date: September 12, 2026 Listing Department BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001. Security Code: 540788 Security ID: ASPIRA Sub: Outcome of Board Meeting Ref: Outcome of Board Meeting held on September 12, 2026 under Regulation 30 of the SEBI (LODR) Regulations, 2015 Dear Sir/Madam, The Board of Directors of the Company in its meeting held on 12th September, 2026 have considered and approved the following matters; 1) To raise Fund for an amount not exceeding Rs. 65,00,00,000/- (Rupees Sixty Five crores only), through a Right Issue to the eligible equity shareholders of the Company as on Record date (to be notified subsequently), in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, SEBI Listing Regulations, along with relevant circulars issued by the Securities and Exchange Board of India, Companies Act, 2013 (“Right Issue”), subject to Shareholders & regulatory approval, if any. The rights issue will be either equity or any other convertible instruments. 2) Constitute of the Right Issue Committee to proceed with the Right Issue and, inter-alia, decide the other terms and conditions of the Right Issue, including deciding on the Record date, determining the rights issue price, rights entitlement ratio, appointment of intermediaries and other related matters. Name of the Composition Category Committee Right Issue Committee Mr. Nikunj Velji Mange Chairman Mr. Vaibhav Odhekar Member Mrs. Kiran Raghavendra awasthi Member Mr. Balkrishna Subhash Talawadekar Member The meeting commenced at 4.00 PM and concluded at 04.30 PM. Kindly take the same on your record. Thanking You. Yours faithfully, For Aspira Pathlab & Diagnostics Limited Nikunj Velji Mange Managing Director DIN: 08489442 INDIA’S FIRST 0227197 5756, 022 2513 9090 www.aspiradiagnostics.com FULLY INTEGRATED LAB support@aspiradiagnostics.com │info@aspiradiagnostics.com